HSBC Holdings
RGNX icon

HSBC Holdings’s Regenxbio RGNX Stock Holding History

HSBC Holdings’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
36,402
-19,428
-35% -$161K ﹤0.01% 2343
2026
Q1 		$467K Buy
55,830
+12,391
+29% +$130K ﹤0.01% 2252
2025
Q4 		$618K Sell
43,439
-32,892
-43% -$410K ﹤0.01% 2201
2025
Q3 		$745K Sell
76,331
-14,473
-16% -$128K ﹤0.01% 1918
2025
Q2 		$745K Buy
90,804
+34,989
+63% +$293K ﹤0.01% 1951
2025
Q1 		$390K Sell
55,815
-29,002
-34% -$216K ﹤0.01% 2212
2024
Q4 		$629K Buy
84,817
+48,310
+132% +$454K ﹤0.01% 2047
2024
Q3 		$376K Buy
36,507
+16,591
+83% +$202K ﹤0.01% 2182
2024
Q2 		$234K Buy
19,916
+5,389
+37% +$83.9K ﹤0.01% 2452
2024
Q1 		$306K Sell
14,527
-13,618
-48% -$242K ﹤0.01% 2431
2023
Q4 		$504K Sell
28,145
-2,437
-8% -$42.9K ﹤0.01% 2051
2023
Q3 		$511K Sell
30,582
-6,889
-18% -$125K ﹤0.01% 1985
2023
Q2 		$757K Buy
37,471
+6,391
+21% +$123K ﹤0.01% 1828
2023
Q1 		$578K Buy
31,080
+14,585
+88% +$323K ﹤0.01% 1990
2022
Q4 		$368K Buy
16,495
+4,276
+35% +$96.7K ﹤0.01% 2429
2022
Q3 		$328K Buy
12,219
+3,813
+45% +$113K ﹤0.01% 2368
2022
Q2 		$210K Sell
8,406
-1,127
-12% -$28.2K ﹤0.01% 2862
2022
Q1 		$321K Buy
+9,533
New +$265K ﹤0.01% 2710
2021
Q3 		– Sell
-7,788
Closed -$308K – 3135
2021
Q2 		$308K Sell
7,788
-6,275
-45% -$224K ﹤0.01% 2497
2021
Q1 		$480K Buy
+14,063
New +$600K ﹤0.01% 1992
2020
Q3 		– Sell
-44,578
Closed -$1.64M – 2833
2020
Q2 		$1.64M Buy
+44,578
New +$1.66M ﹤0.01% 1234
2020
Q1 		– Sell
-5,283
Closed -$217K – 2973
2019
Q4 		$217K Sell
5,283
-1,738
-25% -$68.7K ﹤0.01% 2763
2019
Q3 		$250K Buy
7,021
+883
+14% +$35.8K ﹤0.01% 2752
2019
Q2 		$316K Buy
6,138
+829
+16% +$41.4K ﹤0.01% 2292
2019
Q1 		$304K Buy
+5,309
New +$263K ﹤0.01% 2331

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HSBC Holdings's RGNX Position: Q2 2026 in Review

HSBC Holdings reduced its Regenxbio (RGNX) stake by 35% in Q2 2026, selling an estimated $161K and leaving 36,402 shares worth $438K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

HSBC Holdings first reported a position in RGNX in Q1 2019 and has held it in 25 quarters since. The position peaked at $1.64M in Q2 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • HSBC Holdings held 36,402 shares of Regenxbio worth $438K as of Q2 2026.
  • HSBC Holdings sold 19,428 Regenxbio shares in Q2 2026, an estimated $161K.
  • Regenxbio made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2343 holding.
  • HSBC Holdings first reported a position in Regenxbio in Q1 2019 and has held it in 25 quarters since.
  • HSBC Holdings's Regenxbio position peaked at $1.64M in Q2 2020.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.